Unproven therapies should not be marketed to patients.

Quick Read

“It’s confusing. It’s confusing for even people like me who do this day in and day out,” Alison Bateman-House, a bioethicist at New York University who opposed the federal right-to-try law on the grounds that it would give patients false hope and could potentially lead to patient harm

Quick Read

The FDA said that it had also written to 20 clinics that offer unapproved stem cell treatments, warning them that such products are generally regulated by the agency and encouraging the clinics to contact federal regulators before November 2020, when enforcement will tighten

Quick Read

This briefing note from the Nuffield Council on Bioethics examines the ethical issues that can arise when patients and doctors wish to use experimental treatments

Quick Read

Degrees of Freedom

November 20, 2018

A scientist’s work linking minds and machines helps a paralyzed woman escape her body

Quick Read

New research is zeroing in on a biochemical basis for the placebo effect — possibly opening a Pandora’s box for Western medicine

Quick Read

Most of those undergoing procedure in England did not appear to need it, report shows

Quick Read

Medical treatments targeting the DNA in tumor cells are celebrated, but insurers often won’t cover the skyrocketing cost

Quick Read